REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/05/2025
Back to search
Official data from USPTO
COLOSTAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COLOSTAT
ST13
US500000079220096Class
5, 10, 44
Filing
79220096
Registration
6044427
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
05/06/2025
Trademark type
Word
Nice classes
5, 10, 44
Filing date
09/20/2017
Registration date
05/05/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2020
Last transaction
05/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
81
Owner location
MELBOURNE VIC 3000, AU
Examiner
BRADLEY, EVELYN
Law office
L40
Current location
POST REGISTRATION
Holders and representatives
Holders
Vision Tech Bio Pty Ltd
Representatives
CHARLES G ZUG NELSON MULLINS RILEY & SCARBOROUGH LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biochemical preparations for medical and pharmaceutical usespecifically for cancer or neoplasia; biochemical diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use; chemical diagnostic preparations for medical use ; diagnostic agents for pharmaceutical use being medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical use sold in kit form; diagnostic preparations for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical use sold in kit form; diagnostic substances for medical use; medical diagnostic test strips for cancer or neoplasia detection; cartridges sold prefilled with diagnostic agents for cancer or neoplasia detection; reagents for use in diagnostic tests for medical purposes; reagents for analytical purposes for medical purposes; reagents for medical use; diagnostic reagents for medical purposes; none of the foregoing being in the nature of pharmaceuticals
Class 10
Apparatus for carrying-out diagnostic tests for medical purposesimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus all for the detection of cancer or neoplasia; apparatus for diagnostic purposesmedical diagnostic apparatus for detecting cancer or neoplasia; apparatus for medical diagnostic purposesimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for medical diagnostic use all for the detection of cancer or neoplasia; apparatus sold in kit form for medical diagnostic purposesdiagnostic kits consisting primarily of probesbuffers and reagents for use in testing bodily fluids and bodily biological materials including bloodtissue and stool; diagnostic apparatus for medical purposesdiagnostic kits consisting primarily of probesbuffers and reagents for use in liquid or tissue biopsy testing; diagnostic test kits for the detection of haemoglobin in faeces; medical apparatus for diagnostic purposes for the detection of cancer or neoplasia; medical diagnostic apparatus sold in kit formdiagnostic kits consisting primarily of probesbuffers and reagents for use in testing bodily fluids and bodily biological materialsincluding bloodtissue and stool; medical diagnostic testing apparatusmedical diagnostic testing apparatus for bodily fluids and bodily biological materialsincluding bloodtissue and stool; medical electronic diagnostic apparatusmedical electronic diagnostic apparatus for testing bodily fluids and bodily biological materials including bloodtissue and stool; scientific apparatus for medical diagnostic purposes for testing bodily fluids and bodily biological materials including bloodtissue and stool; tools for medical diagnosticsimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for testing bodily fluids and bodily biological materials including bloodtissue and stool; medical apparatus instrumentsimmunoassay apparatusmolecular apparatusisoelectric focussing apparatusSDS/PAGE apparatusflow cytometry apparatusmass spectrometry apparatusMALDI-TOF apparatusbiosensor technology apparatusevanescent fibre optic apparatus and fluorescence resonance energy transfer apparatus for testing bodily fluids and bodily biological materials including bloodtissue and stool; in vitro diagnostic testing apparatus for medical use for the detection of cancer or neoplasia
Class 44
Medical testing and analysis for diagnostic purposes; surgical diagnostic services; providing medical information; medical services; medical treatment and medical diagnostic testing services; genetic testing services for medical purposes; medical screening services; health screening services in the field of cancer and neoplasia; medical advisory services relating to disease including providing disease risk assessment and related information
Publications
History of USPTO decisions and trademark events.
53 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/26/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/11/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
04/12/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/11/2021
PLGL
ASSIGNED TO PARALEGAL
04/11/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/28/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2020
FIMP
FINAL DISPOSITION PROCESSED
09/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
04/01/2020
OP.T
OPPOSITION TERMINATED NO. 999999
04/01/2020
OP.D
OPPOSITION DISMISSED NO. 999999
04/01/2020
RFNP
REFUSAL PROCESSED BY IB
05/10/2019
OP.I
OPPOSITION INSTITUTED NO. 999999
04/24/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/19/2019
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
04/17/2019
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
04/17/2019
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
04/16/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2019
PUBO
PUBLISHED FOR OPPOSITION
03/19/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/15/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/27/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/27/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/27/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/14/2019
ALIE
ASSIGNED TO LIE
02/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/23/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/23/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/23/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/23/2019
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
12/07/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/02/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/04/2018
GNFR
FINAL REFUSAL E-MAILED
08/04/2018
CNFR
FINAL REFUSAL WRITTEN
08/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/28/2018
RFNT
REFUSAL PROCESSED BY IB
02/03/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2018
RFRR
REFUSAL PROCESSED BY MPU
01/13/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/30/2017
CNRT
NON-FINAL ACTION WRITTEN
12/29/2017
DOCK
ASSIGNED TO EXAMINER
12/25/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/02/2017
Continuous trademark protection
Get notified about every new filing that threatens COLOSTAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.